92 related articles for article (PubMed ID: 1759535)
1. The neuropeptide, head activator, in human placenta and serum from pregnant women.
Sakura H; Aoki S; Ozawa T; Hashimoto T; Sakura N
Acta Endocrinol (Copenh); 1991 Nov; 125(5):454-8. PubMed ID: 1759535
[TBL] [Abstract][Full Text] [Related]
2. Hydra head activator-like immunoreactivity in human brain astrocytomas grade III-IV and the surrounding brain tissue.
Ekman R; Salford L; Brun A; Larsson I
Peptides; 1990; 11(2):271-5. PubMed ID: 2162530
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of a corticotropin-releasing hormone-like peptide from human placenta.
Sasaki A; Tempst P; Liotta AS; Margioris AN; Hood LE; Kent SB; Sato S; Shinkawa O; Yoshinaga K; Krieger DT
J Clin Endocrinol Metab; 1988 Oct; 67(4):768-73. PubMed ID: 3262120
[TBL] [Abstract][Full Text] [Related]
4. The hydra head activator in human blood circulation. Degradation of the synthetic peptide by plasma angiotensin-converting enzyme.
Roberge M; Escher E; Schaller HC; Bodenmüller H
FEBS Lett; 1984 Aug; 173(2):307-13. PubMed ID: 6086405
[TBL] [Abstract][Full Text] [Related]
5. Human placenta and fetal membranes contain peptide YY1-36 and peptide YY3-36.
Xiao Q; Han X; Arany E; Hill D; Challis JR; McDonald TJ
J Endocrinol; 1998 Mar; 156(3):485-92. PubMed ID: 9582505
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of new head-activator analogues and their application for improved radioimmunoassays.
Bodenmüller H; Escher E; Zachmann B; Schilling E
Int J Pept Protein Res; 1987 Jan; 29(1):140-4. PubMed ID: 3570652
[TBL] [Abstract][Full Text] [Related]
7. Beta-endrophin immunoreactivity during human pregnancy.
Chan EC; Smith R
J Clin Endocrinol Metab; 1992 Dec; 75(6):1453-8. PubMed ID: 1464647
[TBL] [Abstract][Full Text] [Related]
8. Expression of hydra head activator in newt tissues and effects on limb regeneration.
Fuentes EJ; Mescher AL; Ekman R; Tsonis PA
In Vivo; 1993; 7(1):59-63. PubMed ID: 8389215
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a new neuropeptide, the head activator from hydra.
Birr C; Zachmann B; Bodenmüller H; Schaller HC
FEBS Lett; 1981 Aug; 131(2):317-21. PubMed ID: 7297679
[No Abstract] [Full Text] [Related]
10. Different molecular and messenger ribonucleic acid forms of insulin-like growth factor-binding protein-3 in the pregnant baboon (Papio anubis).
Gargosky SE; Giudice LC; Rosenfeld RG; Fazleabas AT
J Endocrinol; 1995 Dec; 147(3):449-61. PubMed ID: 8543915
[TBL] [Abstract][Full Text] [Related]
11. Gastrin-releasing peptide-like immunoreactivity is present in human maternal and fetal placental membranes.
Xiao Q; Han X; Challis JR; Hill DJ; Spindel ER; Prasad CJ; Akagi K; McDonald TJ
J Clin Endocrinol Metab; 1996 Oct; 81(10):3766-73. PubMed ID: 8855836
[TBL] [Abstract][Full Text] [Related]
12. The neuropeptide head activator loses its biological acitivity by dimerization.
Bodenmüller H; Schilling E; Zachmann B; Schaller HC
EMBO J; 1986 Aug; 5(8):1825-9. PubMed ID: 2577954
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunosorbent assay for the neuropeptide 'head activator'.
Schaller HC; Bodenmüller H; Zachmann B; Schilling E
Eur J Biochem; 1984 Jan; 138(2):365-71. PubMed ID: 6697993
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of monoclonal antibodies recognizing head activator in precursor form and immunocytochemical localization of head activator precursor and head activator peptide in the neural cell line NH15-CA2 and in hydra.
Schawaller M; Schenck K; Hoffmeister SA; Schaller H; Schaller HC
Differentiation; 1988 Sep; 38(3):149-60. PubMed ID: 3215393
[TBL] [Abstract][Full Text] [Related]
15. The head activator: discovery, characterisation, immunoassays and biological properties in mammals.
Bodenmüller H; Roberge M
Biochim Biophys Acta; 1985 Jul; 825(3):261-7. PubMed ID: 2410027
[No Abstract] [Full Text] [Related]
16. Expression of the oxytocin gene in rat placenta.
Lefebvre DL; Giaid A; Zingg HH
Endocrinology; 1992 Mar; 130(3):1185-92. PubMed ID: 1537285
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactive growth hormone-releasing hormone in rat placenta.
Meigan G; Sasaki A; Yoshinaga K
Endocrinology; 1988 Aug; 123(2):1098-102. PubMed ID: 2899497
[TBL] [Abstract][Full Text] [Related]
18. A head-activator binding protein is present in hydra in a soluble and a membrane-anchored form.
Hampe W; Urny J; Franke I; Hoffmeister-Ullerich SA; Herrmann D; Petersen CM; Lohmann J; Schaller HC
Development; 1999 Sep; 126(18):4077-86. PubMed ID: 10457016
[TBL] [Abstract][Full Text] [Related]
19. Hydra head activator peptide has trophic activity for eukaryotic neurons.
Quach TT; Duchemin AM; Oliver AP; Schrier BK; Wyatt RJ
Brain Res Dev Brain Res; 1992 Jul; 68(1):97-102. PubMed ID: 1521328
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of head activator (HA)-related peptides and development of HA-radioimmunoassay.
Sakura N; Nishijima M; Uchida Y; Tani T; Hashimoto T
Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2327-33. PubMed ID: 3664830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
